<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>沙坦类降压药 &#8211; 元哲咨询</title>
	<atom:link href="https://www.yuanzhezixun.com/tag/shatanleijiangyayao/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.yuanzhezixun.com</link>
	<description>行业研究专家</description>
	<lastBuildDate>Fri, 24 May 2019 14:32:54 +0000</lastBuildDate>
	<language>zh-Hans</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	

<image>
	<url>https://www.yuanzhezixun.com/wp-content/uploads/2021/10/cropped-shcrilogo-c-45x45.jpg</url>
	<title>沙坦类降压药 &#8211; 元哲咨询</title>
	<link>https://www.yuanzhezixun.com</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>国内沙坦类降压药逐一分析</title>
		<link>https://www.yuanzhezixun.com/guoneishatanleijiangyayaozhuyifenxi/</link>
		
		<dc:creator><![CDATA[Yuwenhao]]></dc:creator>
		<pubDate>Fri, 24 May 2019 14:28:57 +0000</pubDate>
				<category><![CDATA[医/药/保健]]></category>
		<category><![CDATA[行业资讯]]></category>
		<category><![CDATA[沙坦类降压药]]></category>
		<guid isPermaLink="false">http://www.yuanzhezixun.com/?p=20451</guid>

					<description><![CDATA[整个高血压市场2018年公立医院的统计大概有400亿的营收，由5类药组成，分别为地平，沙坦，普利，复方和其他类组成，其中地平类占比约35%，沙坦类占比约25%，普利类占比约15%，复方类占比约15%，其他类占比约10%。<div class='yarpp yarpp-related yarpp-related-rss yarpp-related-none yarpp-template-list'>

没有相关文章
</div>
]]></description>
		
		
		
			</item>
	</channel>
</rss>
